ANNAPOLIS, Md., Oct. 30 /PRNewswire/ -- PharmAthene, Inc., a leading biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological terrorism, announced today that it is scheduled to present at the Rodman & Renshaw / Acumen BioFin 9th Annual Healthcare Conference on Tuesday, November 6, 2007 at 10:55 a.m. local time. Presenting for the Company will be David P. Wright, President and Chief Executive Officer. The conference is being held at the New York Palace Hotel in New York City, NY.
A webcast of the Company's presentation will be available both live, and via replay through a link provided on the Company's website at http://www.pharmathene.com/ under the Investor Relations section, or at http://www.wsw.com/webcast/rrshq12/pip.
About PharmAthene, Inc.
PharmAthene was formed to meet the critical needs of the United States and its Allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead programs include Valortim(TM) for the prevention and treatment of anthrax infection and Protexia(R) for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents. For more information on PharmAthene, please visit http://www.pharmathene.com/.
